Intriguingly, both pharmacologically and genetically targeted CD36 of Treg cells specifically induced their intratumoral apoptosis, leading to increased CD8+ T cells infiltration in the tumor and enhanced anti-PD-1 therapeutic effects (37). Here, CD8A is linked to neoplasm.